Presentations & Webinars

Investor Presentation

Sep 15, 2021

TCT 2021 Oral Presentation of SIERRA Results from 75% of Enrollment

Feb 11, 2021

Safety Results with Targeted Conditioning via Iomab-B

Feb 11, 2021

Register for CD33 Combination Trial KOL Call

Nov 11, 2020

Register for Iomab-ACT Update

Oct 21, 2020

Mid-Point Analysis of Pivotal Phase 3 SIERRA Trial Including Material Presented at 2020 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT)

Feb 20, 2020

Dr. Sergio Giralt KOL Event – Interim Phase 3 SIERRA Results

Feb 7, 2019

Feasibility of Administering Iomab-B without Lead-Lined Rooms

Mar 5, 2020

Phase 3 SIERRA Dosimetry Data Supports Iomab-ACT Program ASH 2019

Dec 8, 2019

Actimab-A CLAG-M Combination Interim Results ASH 2019

Dec 8, 2019

• 1
• 2
• 3
• Next »